Johnson & Johnson vs Medtronic plc
JNJ vs MDT — side-by-side comparison from reported financials. JNJ leads 6, MDT leads 3 of 9 comparable metrics.
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
Medtronic plc
MDT · Healthcare
$88.01+0.30%Mixed
| Metric | JNJ | MDT |
|---|---|---|
| Price | $261.79 | $88.01 |
| Market cap | $631B | $113B |
| Revenue (TTM) | $97.9B | $37.5B |
| Revenue growth | +5.6% | +5.2% |
| Net margin | 21.5% | 13.9% |
| Free cash flow | $22.2B | $6.13B |
| Net cash (debt) | ($27.8B) | — |
| 1-year price return | +37.0% | -8.8% |
| P/E | 29.9 | 21.6 |
| P/E vs own history (cheap-side %) | 16% | 96% |
| Dividend yield | 2.00% | 3.22% |
| Return on equity | 26% | 11% |
| CV checks passed | 10 of 11 | 10 of 11 |
| Employees | 140,800 | 95,000 |
Full résumé-style profiles: JNJ CV · MDT CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.